About Us
Founded in 2007, Curemark is a private, clinical-stage biopharmaceutical company developing novel therapies for the treatment of serious unmet needs in neuro-developmental and neurodegenerative disorders. The company has developed the first and only disorder-modifying therapy for Autism. Learn more about our company.
Learn More